Akina provides AI-enabled connected therapy for patients with musculoskeletal conditions.
Akina has raised $3.2M in total funding. The most recent round was Seed. The last funding was announced in January 2025.
Akina's investors include Innosuisse, Springboard Health Angels, Philip Magoulas, Freigeist Capital, Ertan Wittwer.
Akina is headquartered in Zúrich, Switzerland.
Akina provides AI-enabled connected therapy for patients with musculoskeletal conditions.
Akina is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Akina — Funding & Investors." VCBacked, January 24, 2025, https://www.vcbacked.co/company/akina. Accessed October 30, 2026.
VCBacked. (2025). Akina — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/akina
{{cite web |title=Akina — Funding & Investors |url=https://www.vcbacked.co/company/akina |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated